Deputy Director, Global Health Value and Financing

The Deputy Director, Global Health Value and Financing leads IFPMA’s policy and advocacy agenda on the health and economic value of medical innovation and health financing. Reporting to the Executive Director, Global Health, Access, and Financing, this role is key to IFPMA’s efforts to advance its strategies and policies that support patient access to innovative medicines.

Combining strategic capabilities with deep technical expertise, you will translate complex evidence into compelling policy positions, advocacy strategies, and stakeholder engagement plans. Working with public, international and financing organizations, technical experts and pharmaceutical industry leaders, you will help shape policy environments that recognize the value of medical innovation and enable health systems to respond to evolving health needs, improve patient outcomes, and contribute to economic growth and workforce productivity.

This senior and highly visible role requires substantial experience in health economics, health financing, access policy, or related fields. The Deputy Director brings the expertise, credibility, and confidence to lead a strategic discipline, working groups, influence high-level policy developments and build partnerships that advance IFPMA’s strategies and mission to improve health globally through innovation.

• The value of innovative medicines
• Investment in health for improved health outcomes, economic growth, and workforce productivity
• Sustainable healthcare financing, including increasing fiscal space for health, public and private healthcare financing, innovative financing approaches, resource allocation and efficiency
• Valuation of medical innovation, including Health Technology Assessment (HTA) and related methodologies
• Procurement models for innovative medicines and medical technologies
• Universal Health Coverage (UHC)

• Translating complex economic and policy evidence into clear advocacy narratives and recommendations
• Monitoring emerging global policy developments and assessing implications for IFPMA members and strategy
• Anticipating shifts in markets and health valuation approaches (such as technology assessment archetypes) and their potential impact on access
• Drafting policy papers, consultation responses, briefing documents, talking points, and strategic recommendations
• Steering the development of research, economic analyses, policy papers, and evidence packages supporting IFPMA positions
• Providing analytical rigor and ensuring quality of externally commissioned work and consultant outputs
• Identifying evidence gaps and recommending research priorities to strengthen advocacy objectives

• Lead policy and research projects, including management of consultants and external partners
• Convene and provide secretariat support for the Value and Financing Working Group, related subgroups and committees as needed
• Develop annual workplans, objectives, key performance targets, and reporting mechanisms
• Monitor progress against strategic objectives and provide recommendations to IFPMA and GHAF leadership
• Ensure timely delivery of high-quality outputs

• Represent IFPMA in relevant global forums and policy discussions including:
  Economic institutions (e.g. OECD, World Economic Forum), Finance institutions (e.g. World Bank, multilateral development banks), Multilateral policy institutions (e.g. WHO, UN), Political groupings and bodies (e.g. G7, G20), Pharmaceutical industry associations (e.g. EFPIA, PhRMA)
• Build strategic relationships with governments, multilateral organizations, academia, think tanks, and civil society organizations.
• Identify and develop opportunities for…